Evidence map›Paper›PMID 35414649›Full record

ArticleScientific reports2022

Identification of dyes and matrices for dye doped polymer waveguide emitters covering the visible spectrum.

L F Paz, M Caño-García, M A Geday, J M Otón, X Quintana

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

L F PazCEMDATIC, ETSIT Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain. luisfelipe.paz@upm.es.
M Caño-GarcíaCEMDATIC, ETSIT Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain.
M A GedayCEMDATIC, ETSIT Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain.
J M OtónCEMDATIC, ETSIT Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain.
X QuintanaCEMDATIC, ETSIT Telecomunicación, Universidad Politécnica de Madrid, Av. Complutense 30, 28040, Madrid, Spain. x.quintana@upm.es.

Funding

Comunidad de Madrid SINFOTON2-CM"-S2018/NMT-4326European Commission EU H2020 ARIADNE 871464Ministerio de Ciencia e Innovación PID2020-114172RB-C22
6 · The paper itself

Abstract

Polymer based photonic devices offer the possibility cost effective roll-to-roll manufacture of photonic devices. The incorporation of luminescent dopants within a solid polymer waveguide allows for the generation of light within the device avoiding tedious mechanical light coupling. However, when a dopant is embedded in a solid matrix, depending on its concentration and the nature of materials involved, the emitted light may be quenched due to aggregation effects. In this work, thin films and ridge waveguides processed by UV-photolithography have been successfully obtained from a selection of standard photopolymerizable organic monomers, SU8, EpoCore and OrmoStamp doped with a selection of standard dyes like Rhodamine-B, Coumarin-540A and Pyrromethene-580. All structures were manufactured on glass substrates. An analysis of the solubility and optical properties including band gap energy, absorption coefficient ([Formula: see text]) and fluorescence of the doped photoresists at different concentrations has been performed. Photoresists doped with Rhodamine-B shows a higher energy of indirect allowed band gap transition (2.04-2.09 eV) compared to previously reported pure Rhodamine-B thin films (1.95-1.98 eV). Fabrication protocols of dye doped photoresists covering the entire visible spectrum is established.

Identifiers

PMID35414649
PMCPMC9005527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.